2000
DOI: 10.1056/nejm200003303421304
|View full text |Cite
|
Sign up to set email alerts
|

HTLV-II–Associated Cutaneous T-Cell Lymphoma in a Patient with HIV-1 Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
28
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(28 citation statements)
references
References 30 publications
0
28
0
Order By: Relevance
“…[1][2][3][4] In contrast, HTLV-2 is much less pathogenic with only a few cases of variant hairy cell leukemia and neurologic disease associated with infection. [5][6][7][8][9] Both HTLV-1 and HTLV-2 encode the essential Tax protein. Tax acts in trans to activate transcription initiation from the viral promoter.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] In contrast, HTLV-2 is much less pathogenic with only a few cases of variant hairy cell leukemia and neurologic disease associated with infection. [5][6][7][8][9] Both HTLV-1 and HTLV-2 encode the essential Tax protein. Tax acts in trans to activate transcription initiation from the viral promoter.…”
Section: Introductionmentioning
confidence: 99%
“…2,3 In contrast, the correlation between HTLV-2 infection and hematopoietic malignancies is still controversial. [4][5][6][7] However, HTLV-2 infection of T cells in vitro results in spontaneous cell proliferation and transformation. 6,[8][9][10][11] In addition, HTLV-2 can be found in some patients with neurodegenerative and lymphoproliferative disorders and in a significant fraction (up to 10%) of intravenous drug users, frequently co-infected with human immunodeficiency virus (HIV)-1.…”
Section: Introductionmentioning
confidence: 99%
“…Even if originally isolated from a case of atypical hairy T-cell leukemia (1,7) and capable of inducing the survival and proliferation of CD34 ϩ cells (8,9), of immortalizing human lymphocytes, or of transforming rat cells in vitro (10 -13), HTLV-2 has not been epidemiologically demonstrated to be the agent of a malignant hematological disease (14). There is in fact only one cutaneous T cell lymphoma case report where HTLV-2 was likely to be involved in the pathogenesis of the disease (15). Nevertheless, an overall increase of the CD8 ϩ T-cell population is often detected in HTLV-2-infected individuals (16).…”
mentioning
confidence: 99%